Drug:
Reaction: GENERAL PHYSICAL HEALTH DETERIORATION
20250101 - 20251231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 25037161 |
DO |
2 | |
Death, General physical health deterioration, |
||||
RIBOCICLIB, |
||||
| 602 | 25037205 |
FR |
83 | 1 |
General physical health deterioration, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 603 | 25037212 |
CO |
77 | 1 |
Death, Oxygen saturation decreased, General physical health deterioration, |
||||
DAROLUTAMIDE, |
||||
| 604 | 25037246 |
CA |
44 | 2 |
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Antiphospholipid antibodies, Anxiety, Arthralgia, Arthritis, Arthropathy, Aspartate aminotransferase abnormal, Asthenia, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, Chest pain, Colitis ulcerative, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depressed mood, Depression, Discomfort, Dislocation of vertebra, Drug tolerance decreased, Duodenal ulcer perforation, Dyspnoea, Ear infection, Exostosis, Feeling hot, Folliculitis, Foot deformity, Functional gastrointestinal disorder, Gastrointestinal disorder, General physical health deterioration, Grip strength decreased, Hand deformity, Headache, Hepatic cirrhosis, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Impaired healing, Insomnia, Joint dislocation, Joint stiffness, Joint swelling, Laryngitis, Lip dry, Liver disorder, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Oedema peripheral, Osteoarthritis, Osteoporosis, Pancreatitis, Paraesthesia, Peripheral swelling, Porphyria acute, Protein total increased, Pruritus, Pyrexia, Rectal haemorrhage, Red blood cell sedimentation rate increased, Respiratory disorder, Retinitis, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Visual impairment, Weight decreased, Weight increased, White blood cell count increased, Wound infection, |
||||
LANSOPRAZOLE, PANTOPRAZOLE, LORAZEPAM, LORAZEPAM, MESALAMINE, RAMIPRIL, CAFFEINE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, AZATHIOPRINE SODIUM, CALCIUM GLUCONATE, CELECOXIB, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, LISINOPRIL, MAGNESIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREGABALIN, QUETIAPINE FUMARATE, QUETIAPINE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 605 | 25037346 |
CO |
50 | 2 |
Dyspnoea, General physical health deterioration, |
||||
ABEMACICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 606 | 25037426 |
CA |
14 | 1 |
Erythema, Fatigue, General physical health deterioration, Pyrexia, Rash macular, |
||||
PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PREDNISONE, URSODIOL, URSOSIOL, VEDOLIZUMAB, LANSOPRAZOLE, |
||||
| 607 | 25037765 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 608 | 25037804 |
US |
1 | |
Sepsis, Infection, Anaemia, Post transplant lymphoproliferative disorder, Diabetes mellitus inadequate control, Pain, Injury, Diabetic wound, Immune system disorder, General physical health deterioration, Mobility decreased, Impaired healing, Incoherent, Psychotic disorder, Adverse drug reaction, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, |
||||
| 609 | 25037885 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 610 | 25037906 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 611 | 25037913 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 612 | 25037989 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 613 | 25038456 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 614 | 25038466 |
TR |
1 | |
General physical health deterioration, Pneumonia, |
||||
FOLIC ACID, CLOZAPINE, |
||||
| 615 | 25038478 |
US |
41 | 2 |
Food poisoning, Blood potassium decreased, Dehydration, General physical health deterioration, |
||||
ADALIMUMAB, |
||||
| 616 | 25038793 |
US |
81 | 2 |
General physical health deterioration, Product dose omission issue, |
||||
MEPOLIZUMAB, |
||||
| 617 | 25029088 |
IT |
||
Encephalopathy, Hallucination, Confusional state, Psychomotor hyperactivity, General physical health deterioration, |
||||
VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, |
||||
| 618 | 25029093 |
CR |
2 | |
Syncope, Pain, General physical health deterioration, Headache, Nausea, Weight loss poor, Drug ineffective, |
||||
LIRAGLUTIDE, LIRAGLUTIDE, LIRAGLUTIDE, LIRAGLUTIDE, LIRAGLUTIDE, |
||||
| 619 | 25029349 |
JP |
31 | 2 |
General physical health deterioration, Drug ineffective, Injection site pain, |
||||
MESALAMINE, MIRIKIZUMAB-MRKZ, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, MESALAMINE, |
||||
| 620 | 25029415 |
CA |
44 | 2 |
Grip strength, Ear infection, Drug tolerance decreased, Helicobacter infection, Respiratory disorder, Sleep disorder due to a general medical condition, Arthropathy, Asthenia, Gastrointestinal disorder, General physical health deterioration, Blood cholesterol increased, Grip strength decreased, Hand deformity, Gait disturbance, Foot deformity, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Folliculitis, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LORAZEPAM, CALCIUM, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CAFFEINE, CAFFEINE CITRATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FLUOROMETHOLONE, AZATHIOPRINE, ABATACEPT, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, RITUXIMAB, RITUXIMAB, ALBUTEROL SULFATE, VITAMIN C, |
||||
| 621 | 25029445 |
CA |
2 | |
Uveitis, General physical health deterioration, Injury associated with device, Product complaint, |
||||
ADALIMUMAB-ADAZ, |
||||
| 622 | 25029838 |
FR |
||
General physical health deterioration, Cardiac failure, Dermatitis bullous, Pulmonary embolism, Dermatitis, Fall, Oedema peripheral, Asthenia, Diabetes mellitus inadequate control, Dyspnoea, Hypothalamic pituitary adrenal axis suppression, Product use issue, Product use in unapproved indication, Off label use, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, FUROSEMIDE, CANDESARTAN, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 623 | 25029953 |
US |
||
General physical health deterioration, |
||||
RAVULIZUMAB, |
||||
| 624 | 25030279 |
CO |
57 | 2 |
Decreased immune responsiveness, Joint destruction, Decreased appetite, Concomitant disease aggravated, Drug ineffective, General physical health deterioration, Body height decreased, Pain in extremity, Mobility decreased, Pulmonary mass, Vomiting, Fatigue, Gait disturbance, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE, LETROZOLE, PREGABALIN, PREGABALIN, LOSARTAN, |
||||
| 625 | 25030553 |
CA |
44 | 2 |
Pulmonary fibrosis, Mobility decreased, Anti-cyclic citrullinated peptide antibody positive, Blister, Synovitis, Swollen joint count increased, Swelling, Systemic lupus erythematosus, Hypersensitivity, Alopecia, Maternal exposure during pregnancy, Rash, Pain, Type 2 diabetes mellitus, Contusion, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Condition aggravated, Rheumatoid arthritis, Musculoskeletal stiffness, Hand deformity, Folliculitis, Glossodynia, Abdominal discomfort, Drug tolerance decreased, Rheumatic fever, Confusional state, Headache, Arthropathy, Nausea, General physical health deterioration, Hypertension, Pemphigus, Dyspnoea, Gait disturbance, Contraindicated product administered, Arthralgia, Gastrointestinal disorder, Migraine, Discomfort, Joint swelling, Lower respiratory tract infection, Vomiting, Muscle injury, Pyrexia, Dyspepsia, Off label use, Product use issue, Prescribed underdose, Drug ineffective, Impaired healing, Wound, Exposure during pregnancy, Nasopharyngitis, Therapeutic product effect decreased, Pruritus, Helicobacter infection, Rheumatoid factor positive, Blood cholesterol increased, Sinusitis, Pericarditis, Pneumonia, Treatment failure, Ill-defined disorder, Infection, Peripheral swelling, Irritable bowel syndrome, Weight increased, Drug intolerance, Duodenal ulcer perforation, Infusion related reaction, Pain in extremity, Fatigue, |
||||
DICLOFENAC, DICLOFENAC SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, TOFACITINIB, TOFACITINIB, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, HYDROCORTISONE, HYDROCORTISONE, ACETAMINOPHEN AND CODEINE, CORTISONE ACETATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, HYDROCORTISONE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, FOLIC ACID, FOLIC ACID, FOLIC ACID, ACETAMINOPHEN AND CODEINE, RITUXIMAB, RITUXIMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, OXYCODONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, HYDROXYCHLOROQUINE, GOLIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ETANERCEPT, ETANERCEPT, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, INFLIXIMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TOFACITINIB, DESOXIMETASONE, DESOXIMETASONE, LEFLUNOMIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, SULFASALAZINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, GOLIMUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, USTEKINUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ALENDRONATE SODIUM, CAFFEINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 626 | 25030592 |
PA |
1 | |
Bedridden, General physical health deterioration, Decubitus ulcer, Skin ulcer, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, ENZALUTAMIDE, |
||||
| 627 | 25031048 |
DE |
||
Respiratory failure, Pneumonia fungal, Malignant neoplasm progression, General physical health deterioration, Cardiac failure, Anaphylactic reaction, Atrial fibrillation, Atypical pneumonia, Pneumonia, Tumour lysis syndrome, Respiratory acidosis, Lymphadenopathy mediastinal, Liver disorder, Blood bilirubin increased, Splenomegaly, Pyrexia, |
||||
RITUXIMAB, PIRTOBRUTINIB, |
||||
| 628 | 25031247 |
CA |
||
Dysstasia, Balance disorder, Defaecation urgency, Gait disturbance, Grunting, Hypotension, Ill-defined disorder, Malaise, Pulmonary oedema, Diarrhoea, Rash pruritic, Asthenia, Pain, Fatigue, Injection site pain, Cardiac disorder, Cardiac failure congestive, Cough, Hypersensitivity, Pruritus, Urticaria, Vomiting, Drug ineffective, Wrong technique in product usage process, General physical health deterioration, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, AMLODIPINE, HYDROXYCHLOROQUINE, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, LOSARTAN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, ROSUVASTATIN CALCIUM, |
||||
| 629 | 25031365 |
US |
78 | 1 |
Rectal haemorrhage, General physical health deterioration, Rectal haemorrhage, |
||||
RISANKIZUMAB-RZAA, |
||||
| 630 | 25031563 |
CA |
59 | 2 |
Osteoporosis, Product use issue, Nausea, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Hepatic cirrhosis, Joint stiffness, Incorrect route of product administration, Mobility decreased, C-reactive protein increased, Treatment failure, Infection, Product use in unapproved indication, Osteoarthritis, Headache, Exposure during pregnancy, Adverse drug reaction, Rheumatoid factor positive, Abdominal discomfort, Dizziness, Bone erosion, Pemphigus, Visual impairment, Lupus-like syndrome, Joint swelling, Foot deformity, Decreased appetite, Ear infection, Joint dislocation, Pain in extremity, Pneumonia, Contraindicated product administered, Rheumatoid arthritis, Pain, Alopecia, Condition aggravated, Drug hypersensitivity, Therapeutic product effect decreased, Pericarditis, General physical health deterioration, Synovitis, Discomfort, Retinitis, Hypersensitivity, Wound, Off label use, Laryngitis, Systemic lupus erythematosus, Crohn^s disease, Oedema peripheral, Rash, Hand deformity, Therapeutic product effect incomplete, Malaise, Drug intolerance, Hepatic enzyme increased, Hypoaesthesia, Exostosis, Musculoskeletal stiffness, Red blood cell sedimentation rate increased, Arthritis, Glossodynia, Drug ineffective, Fatigue, |
||||
ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, CERTOLIZUMAB PEGOL, GOLIMUMAB, DESOXIMETASONE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, VITAMIN C, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ETANERCEPT, SULFASALAZINE, CALCIUM, CALCIUM CARBONATE, RAMIPRIL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SECUKINUMAB, PREDNISONE, HYDROXYCHLOROQUINE, LEFLUNOMIDE, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, MORPHINE SULFATE, ADALIMUMAB-ADAZ, HYDROCORTISONE ACETATE, ETANERCEPT, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, QUETIAPINE FUMARATE, QUETIAPINE, ERGOCALCIFEROL, CERTOLIZUMAB PEGOL, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, SECUKINUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, MINOCYCLINE HYDROCHLORIDE, TOCILIZUMAB, ALENDRONATE SODIUM, APREMILAST, INFLIXIMAB, CORTISONE ACETATE, TOCILIZUMAB, ABATACEPT, DESOXIMETASONE, LEFLUNOMIDE, ALENDRONATE SODIUM, SARILUMAB, GOLIMUMAB, SECUKINUMAB, RITUXIMAB-ABBS, USTEKINUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, HYDROMORPHONE HYDROCHLORIDE, TOFACITINIB, DICLOFENAC, DICLOFENAC SODIUM, LORAZEPAM, CAFFEINE CITRATE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION, HYDROMORPHONE HYDROCHLORIDE, SULFASALAZINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, AZATHIOPRINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 631 | 25031571 |
74 | 2 | |
Product dispensing error, Product prescribing error, Inappropriate schedule of product administration, Product communication issue, General physical health deterioration, Haemoptysis, Anaemia, Thrombocytopenia, Neutropenia, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 632 | 25031787 |
US |
2 | |
General physical health deterioration, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 633 | 25031809 |
DO |
2 | |
Death, Breast cancer, Malignant neoplasm progression, General physical health deterioration, |
||||
RIBOCICLIB, |
||||
| 634 | 25031837 |
CA |
68 | 2 |
Diarrhoea, General physical health deterioration, Nausea, Pain in extremity, Pneumonia, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIMENHYDRINATE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 635 | 25031851 |
US |
1 | |
General physical health deterioration, Product dose omission issue, |
||||
MEPOLIZUMAB, |
||||
| 636 | 25031928 |
CA |
43 | 2 |
Hypoaesthesia, Hypertension, Hypercholesterolaemia, Hepatic enzyme increased, Hand deformity, Glossodynia, General physical health deterioration, Pericarditis, Gastrooesophageal reflux disease, Lower respiratory tract infection, Maternal exposure during pregnancy, Drug ineffective, Drug intolerance, Off label use, Product use in unapproved indication, Product quality issue, Intentional product use issue, |
||||
ALENDRONATE SODIUM, APREMILAST, ATOMOXETINE HYDROCHLORIDE, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, ERENUMAB-AOOE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLD, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, LAMOTRIGINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, OXYCODONE, ABATACEPT, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RITUXIMAB, RITUXIMAB, RAMIPRIL, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, TOFACITINIB, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, USTEKINUMAB, VITAMIN C, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, TOFACITINIB, TOFACITINIB, CALCIUM, CYANOCOBALAMIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, SULFASALAZINE, FISH OIL, |
||||
| 637 | 25032163 |
GB |
1 | |
Cellulitis, General physical health deterioration, Fall, Diabetes mellitus, Diarrhoea, Anaemia, |
||||
CLOZAPINE, |
||||
| 638 | 25032482 |
US |
55 | 1 |
General physical health deterioration, |
||||
ROZANOLIXIZUMAB, |
||||
| 639 | 25032540 |
CA |
2 | |
Abdominal discomfort, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Fatigue, Fibromyalgia, Fluid retention, Folliculitis, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, General symptom, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Walking aid user, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, CALCIUM CARBONATE, CALCIUM CARBONATE, VITAMIN C, DICLOFENAC SODIUM, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, LORAZEPAM, CAFFEINE CITRATE, DESOGESTREL AND ETHINYL ESTRADIOL, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, LORAZEPAM, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LANSOPRAZOLE, |
||||
| 640 | 25032620 |
GB |
54 | 1 |
Rheumatoid arthritis, General physical health deterioration, Illness, Fatigue, Mental disorder, Drug ineffective, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 641 | 25032844 |
US |
2 | |
Hospitalisation, Congenital anomaly, Overdose, Drug dependence, Coma, Learning disability, General physical health deterioration, Joint swelling, Gait disturbance, Ocular hyperaemia, Dysstasia, Dyspnoea, Hypertension, Anxiety, Peripheral swelling, |
||||
OXYCODONE HYDROCHLORIDE, MORPHINE SULFATE, |
||||
| 642 | 25033023 |
US |
2 | |
General physical health deterioration, |
||||
LIRAGLUTIDE, |
||||
| 643 | 25033065 |
FR |
91 | 2 |
General physical health deterioration, Psychomotor skills impaired, Fall, Confusional state, Hyponatraemia, Inappropriate antidiuretic hormone secretion, Accidental overdose, Product prescribing error, |
||||
SERTRALINE, |
||||
| 644 | 25033247 |
US |
1 | |
Disease progression, General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 645 | 25033251 |
IN |
70 | 2 |
General physical health deterioration, Fatigue, Recurrent cancer, |
||||
OBINUTUZUMAB, |
||||
| 646 | 25033420 |
CA |
45 | 2 |
Salmonella bacteraemia, Hospitalisation, Hypertension, Frequent bowel movements, General physical health deterioration, Abdominal pain, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 647 | 25028782 |
FR |
81 | 1 |
General physical health deterioration, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 648 | 25028790 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 649 | 25028810 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 650 | 25026322 |
CA |
||
General physical health deterioration, Rheumatoid arthritis, Throat irritation, Drug ineffective, Off label use, |
||||
RITUXIMAB, RITUXIMAB, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, PREDNISONE, |
||||
| 651 | 25026356 |
US |
69 | 2 |
Cerebrospinal fluid drainage, Pain, Arthralgia, Musculoskeletal stiffness, General physical health deterioration, |
||||
UPADACITINIB, |
||||
| 652 | 25027438 |
US |
2 | |
General physical health deterioration, Dry mouth, Mental disorder, |
||||
DUPILUMAB, |
||||
| 653 | 25021059 |
FR |
88 | 2 |
General physical health deterioration, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 654 | 25021236 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 655 | 25021369 |
US |
84 | 2 |
General physical health deterioration, Device difficult to use, Product communication issue, |
||||
EVOLOCUMAB, |
||||
| 656 | 25021554 |
TH |
10 | 2 |
Renal transplant failure, Renal transplant, General physical health deterioration, |
||||
| 657 | 25021593 |
CA |
77 | 2 |
Movement disorder, General physical health deterioration, Gait disturbance, Injection site bruising, Circumstance or information capable of leading to medication error, Drug dose omission by device, |
||||
ETANERCEPT, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE SULFATE, |
||||
| 658 | 25021828 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 659 | 25021847 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 660 | 25021859 |
VN |
||
General physical health deterioration, |
||||
OSIMERTINIB, |
||||
| 661 | 25021931 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 662 | 25021962 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 663 | 25021978 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 664 | 25022146 |
US |
80 | 1 |
Myocardial infarction, Coronary artery occlusion, General physical health deterioration, |
||||
INSULIN ASPART, |
||||
| 665 | 25022304 |
CA |
40 | 2 |
Finger deformity, Adverse reaction, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ALENDRONATE SODIUM, APREMILAST, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, BUPRENORPHINE, CANDESARTAN, CANDESARTAN, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CALCIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, MIRABEGRON, MIRABEGRON, MIRABEGRON, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, NICOTINAMIDE, MEPOLIZUMAB, MEPOLIZUMAB, OXYCODONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, TETRACYCLINE HYDROCHLORIDE, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VITAMIN C, DICLOFENAC SODIUM, DICLOFENAC SODIUM, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 666 | 25022468 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 667 | 25022469 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 668 | 25022471 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 669 | 25022473 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 670 | 25022475 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 671 | 25022476 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 672 | 25022477 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 673 | 25022478 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 674 | 25022479 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 675 | 25022480 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 676 | 25022482 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 677 | 25022484 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 678 | 25022568 |
CO |
66 | 1 |
General physical health deterioration, Haematochezia, Vomiting, Decreased appetite, Asthenia, |
||||
| 679 | 25022969 |
RO |
1 | |
General physical health deterioration, Blood test abnormal, |
||||
EVEROLIMUS, EVEROLIMUS, |
||||
| 680 | 25023181 |
IN |
58 | 2 |
General physical health deterioration, Disease recurrence, |
||||
TEMOZOLOMIDE, |
||||
| 681 | 25023202 |
DE |
78 | 1 |
Malignant neoplasm progression, Sepsis, General physical health deterioration, Malignant neoplasm progression, Neutropenic infection, Febrile infection, Pneumonia, Splenomegaly, Granulocyte percentage decreased, Haematocrit decreased, Mean cell haemoglobin increased, Mean cell haemoglobin concentration increased, Mean platelet volume decreased, Monocyte count increased, Platelet distribution width decreased, Plateletcrit decreased, Red blood cell count decreased, Platelet count decreased, Haemoglobin decreased, Lymphocytosis, |
||||
LENALIDOMIDE, PIRTOBRUTINIB, PIRTOBRUTINIB, PIRTOBRUTINIB, RITUXIMAB, BISOPROLOL FUMARATE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, ACYCLOVIR, |
||||
| 682 | 25023500 |
FR |
||
Hallucination, General physical health deterioration, Weight loss poor, Delirium, |
||||
| 683 | 25023777 |
DE |
72 | 2 |
General physical health deterioration, Neoplasm progression, |
||||
LETROZOLE, LETROZOLE TABLETS, PALBOCICLIB, |
||||
| 684 | 25023812 |
CN |
2 | |
General physical health deterioration, |
||||
INSULIN GLARGINE, |
||||
| 685 | 25023817 |
RO |
||
White blood cell count increased, Platelet count decreased, Pleural effusion, General physical health deterioration, |
||||
OSIMERTINIB, |
||||
| 686 | 25023850 |
US |
||
General physical health deterioration, |
||||
SUTIMLIMAB-JOME, |
||||
| 687 | 25024057 |
87 | 1 | |
Subdural haemorrhage, Fall, Head injury, General physical health deterioration, Nervousness, Rib fracture, |
||||
RIVAROXABAN, |
||||
| 688 | 25024666 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 689 | 25025126 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 690 | 25025471 |
CA |
44 | 2 |
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Antiphospholipid antibodies, Anxiety, Arthralgia, Arthritis, Arthropathy, Aspartate aminotransferase abnormal, Asthenia, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, Chest pain, Colitis ulcerative, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depressed mood, Depression, Discomfort, Dislocation of vertebra, Drug tolerance decreased, Duodenal ulcer perforation, Dyspnoea, Ear infection, Exostosis, Feeling hot, Folliculitis, Foot deformity, Functional gastrointestinal disorder, Gastrointestinal disorder, General physical health deterioration, Grip strength decreased, Hand deformity, Headache, Hepatic cirrhosis, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Impaired healing, Insomnia, Joint dislocation, Joint stiffness, Joint swelling, Laryngitis, Lip dry, Liver disorder, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Oedema peripheral, Osteoarthritis, Osteoporosis, Pancreatitis, Paraesthesia, Peripheral swelling, Porphyria acute, Protein total increased, Pruritus, Pyrexia, Rectal haemorrhage, Red blood cell sedimentation rate increased, Respiratory disorder, Retinitis, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Visual impairment, Weight decreased, Weight increased, White blood cell count increased, Wound infection, |
||||
MESALAMINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LANSOPRAZOLE, RAMIPRIL, CAFFEINE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, LORAZEPAM, AZATHIOPRINE SODIUM, CALCIUM GLUCONATE, CELECOXIB, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, LISINOPRIL, LORAZEPAM, MAGNESIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREGABALIN, QUETIAPINE FUMARATE, QUETIAPINE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 691 | 25025501 |
US |
1 | |
Haemoglobin decreased, General physical health deterioration, Inappropriate schedule of product administration, |
||||
TRIFLURIDINE AND TIPIRACIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 692 | 25025517 |
CA |
2 | |
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Arthropathy, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage I, Bronchitis, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Crohn^s disease, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug-induced liver injury, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Ear infection, Exostosis, Fatigue, Fibromyalgia, Folliculitis, Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Knee arthroplasty, Laryngitis, Liver function test increased, Liver injury, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Red blood cell sedimentation rate increased, Retinitis, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Seronegative arthritis, Sinusitis, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Tachycardia, Type 2 diabetes mellitus, Upper respiratory tract infection, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, Disability, Loss of personal independence in daily activities, Walking aid user, Prescribed overdose, Prescribed underdose, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, APREMILAST, AZATHIOPRINE, CALCIUM, CALCIUM CARBONATE, ANTACID, CELECOXIB, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CLONIDINE HYDROCHLORIDE, CLONIDINE, HYDROCORTISONE, CORTISONE ACETATE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 693 | 25025538 |
CA |
67 | 1 |
Skin discolouration, Abdominal discomfort, Dysphonia, Dyspnoea, Flatulence, General physical health deterioration, Irritability, Malaise, Mobility decreased, Muscle spasms, Parasitic gastroenteritis, Pneumonia, Anal incontinence, Weight increased, Respiratory tract infection fungal, Umbilical hernia, Viral infection, Weight decreased, Wheezing, Incorrect dose administered, Inappropriate schedule of product administration, Asthenia, Asthma, Blood pressure increased, Chest pain, Cough, Diarrhoea, Diverticulitis, Sinusitis, Off label use, COVID-19, Sinus disorder, Tremor, Product dose omission issue, Nephrolithiasis, Oesophageal pain, |
||||
AMOXICILLIN, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, RAMIPRIL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, ALBUTEROL SULFATE, |
||||
| 694 | 25025604 |
IT |
54 | 1 |
General physical health deterioration, Febrile neutropenia, Off label use, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 695 | 25025625 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 696 | 25015422 |
NL |
76 | 1 |
Cardiac failure, Loss of personal independence in daily activities, General physical health deterioration, Dyspnoea, Fatigue, Haematoma, Orthostatic hypotension, Cardiac disorder, On and off phenomenon, Loss of personal independence in daily activities, Appetite disorder, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 697 | 25015476 |
US |
||
Death, General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 698 | 25015720 |
FR |
78 | 1 |
General physical health deterioration, |
||||
RITUXIMAB, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, VINCRISTINE SULFATE, |
||||
| 699 | 25015785 |
US |
1 | |
Dyspnoea, Product delivery mechanism issue, General physical health deterioration, |
||||
| 700 | 25016027 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28